216 related articles for article (PubMed ID: 20513819)
1. Atypical idiopathic intracranial hypertension: normal BMI and older patients.
Bruce BB; Kedar S; Van Stavern GP; Corbett JJ; Newman NJ; Biousse V
Neurology; 2010 Jun; 74(22):1827-32. PubMed ID: 20513819
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Idiopathic Intracranial Hypertension in Patients Over 50 Years of Age: A multicenter clinical cohort study.
Downie PA; Chen JJ; Bhatti MT; Melson AT; Van Stavern GP; McClelland CM; Lindgren BR; Sharieff JA; Lee MS
Am J Ophthalmol; 2021 Apr; 224():96-101. PubMed ID: 33253662
[TBL] [Abstract][Full Text] [Related]
3. Self-Reported Weight and Height Among Idiopathic Intracranial Hypertension Patients.
Parish DC; Bidot S; Bruce BB; Micieli JA; Blanch RJ; Newman AB; Newman NJ; Biousse V
J Neuroophthalmol; 2020 Jun; 40(2):157-162. PubMed ID: 31842150
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic intracranial hypertension: relation between obesity and visual outcomes.
Szewka AJ; Bruce BB; Newman NJ; Biousse V
J Neuroophthalmol; 2013 Mar; 33(1):4-8. PubMed ID: 22217456
[TBL] [Abstract][Full Text] [Related]
5. Long-term visual outcome in a Danish population of patients with idiopathic intracranial hypertension.
Hatem CF; Yri HM; Sørensen AL; Wegener M; Jensen RH; Hamann S
Acta Ophthalmol; 2018 Nov; 96(7):719-723. PubMed ID: 29405582
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic intracranial hypertension in men.
Bruce BB; Kedar S; Van Stavern GP; Monaghan D; Acierno MD; Braswell RA; Preechawat P; Corbett JJ; Newman NJ; Biousse V
Neurology; 2009 Jan; 72(4):304-9. PubMed ID: 18923135
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic intracranial hypertension in atypical demographics.
Donaldson L; Jhaveri A; Micieli J; Margolin E
J Neurol Sci; 2022 Jun; 437():120271. PubMed ID: 35525063
[TBL] [Abstract][Full Text] [Related]
8. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Peragallo JH; Newman NJ; Biousse V
Br J Ophthalmol; 2019 Oct; 103(10):1429-1435. PubMed ID: 30530819
[TBL] [Abstract][Full Text] [Related]
9. Differing presenting features of idiopathic intracranial hypertension in the UK and US.
Blanch RJ; Vasseneix C; Liczkowski A; Yiangou A; Aojula A; Micieli JA; Mollan SP; Newman NJ; Biousse V; Bruce BB; Sinclair A
Eye (Lond); 2019 Jun; 33(6):1014-1019. PubMed ID: 30783258
[TBL] [Abstract][Full Text] [Related]
10. Impact of Pregnancy on Papilledema and Vision Loss in Idiopathic Intracranial Hypertension Patients: A Chart Review and Case Series of 13 Patients.
Lambert-Cheatham NA; Nagia L; Pasmanter NR; Pellizzari R; Lee B; Miller NJ; Kaufman DI
J Neuroophthalmol; 2024 Jun; 44(2):206-211. PubMed ID: 37540562
[TBL] [Abstract][Full Text] [Related]
11. Contrast sensitivity in Idiopathic Intracranial Hypertension.
Rehman O; Ichhpujani P; Kumar S
Rom J Ophthalmol; 2020; 64(4):380-386. PubMed ID: 33367175
[No Abstract] [Full Text] [Related]
12. Functional visual loss in idiopathic intracranial hypertension.
Ney JJ; Volpe NJ; Liu GT; Balcer LJ; Moster ML; Galetta SL
Ophthalmology; 2009 Sep; 116(9):1808-1813.e1. PubMed ID: 19643491
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic intracranial hypertension is not benign: a long-term outcome study.
Yri HM; Wegener M; Sander B; Jensen R
J Neurol; 2012 May; 259(5):886-94. PubMed ID: 22008872
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic Intracranial Hypertension-A Comparison of Clinical Characteristics Between 4 Medical Centers in Different Geographic Regions of the World.
Rosenblatt A; Klein A; Roemer S; Borruat FX; Meira D; Silva M; Gökçay F; Çelebisoy N; Kesler A
J Neuroophthalmol; 2016 Sep; 36(3):280-4. PubMed ID: 27261947
[TBL] [Abstract][Full Text] [Related]
15. A Comparison Between the Clinical Features of Pseudotumor Cerebri Secondary to Tetracyclines and Idiopathic Intracranial Hypertension.
Orme DR; Vegunta S; Miller MA; Warner JEA; Bair C; McFadden M; Crum AV; Digre KB; Katz BJ
Am J Ophthalmol; 2020 Dec; 220():177-182. PubMed ID: 32738227
[TBL] [Abstract][Full Text] [Related]
16. Thinning of the Skull Base and Calvarial Thickness in Patients With Idiopathic Intracranial Hypertension.
Barke M; Castro HM; Adesina OO; Chuang AZ; Do T; Patel RP; Richani K
J Neuroophthalmol; 2022 Jun; 42(2):192-198. PubMed ID: 35195543
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric papilledema in idiopathic intracranial hypertension.
Bidot S; Bruce BB; Saindane AM; Newman NJ; Biousse V
J Neuroophthalmol; 2015 Mar; 35(1):31-6. PubMed ID: 25494197
[TBL] [Abstract][Full Text] [Related]
18. Predictive role of presenting symptoms and clinical findings in idiopathic intracranial hypertension.
Radojicic A; Vukovic-Cvetkovic V; Pekmezovic T; Trajkovic G; Zidverc-Trajkovic J; Jensen RH
J Neurol Sci; 2019 Apr; 399():89-93. PubMed ID: 30782528
[TBL] [Abstract][Full Text] [Related]
19. Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
Mikkilineni S; Trobe JD; Cornblath WT; De Lott L
J Neuroophthalmol; 2019 Jun; 39(2):186-190. PubMed ID: 30153119
[TBL] [Abstract][Full Text] [Related]
20. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension.
Stiebel-Kalish H; Kalish Y; Lusky M; Gaton DD; Ehrlich R; Shuper A
Am J Ophthalmol; 2006 Aug; 142(2):279-83. PubMed ID: 16876509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
